AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26630974
Drug: Vitamin K1
RxNorm normalized name: vitamin K1
DrugBank: Phylloquinone (DB01022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin K1 < 0.76 and 25(OH)D < 50 nmol/l
Trial: 24131095
Drug: Intradermal radiofrequency
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal radiofrequency (RF) prior to hyaluronic acid (HA) filler
Trial: 11835456
Drug: Intramuscular botulinum
RxNorm normalized name: Clostridium botulinum
DrugBank: Clostridium botulinum (DB14223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular botulinum toxin type A (BT‐A) with electrical stimulation (Group A, n = 6)
Trial: 11835456
Drug: Intramuscular botulinum
RxNorm normalized name: Clostridium botulinum
DrugBank: Clostridium botulinum (DB14223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular botulinum toxin type A (BT‐A) alone (Group B, n = 6)
Trial: 2590625
Drug: Coal tar
RxNorm normalized name: Coal Tar
DrugBank: Coal tar (DB11082)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coal tar gel
Trial: 5473608
Drug: Electrolyte solution
RxNorm normalized name: electrolyte solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrolyte solution containing both glucose and glycine
Trial: 5473608
Drug: Electrolyte solution
RxNorm normalized name: electrolyte solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrolyte solution containing glucose
Trial: 5473608
Drug: Electrolyte solution
RxNorm normalized name: electrolyte solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrolyte solution containing glycine
Trial: 24247812
Drug: Metoprolol IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol IR 50 mg four times daily
Trial: 24247812
Drug: Metoprolol IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol IR 100 mg twice daily
Trial: 11413739
Drug: Azelastine (1.12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine (1.12 mg/day) nasal spray administered twice daily
Trial: 11413739
Drug: Levocabastine (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levocabastine (0.4 mg/day) nasal spray administered twice daily
Trial: 30575346
Drug: Photopheresis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photopheresis with standard immunosuppression therapy (tacrolimus, mycophenolate, prednisone) for 10-15 sessions during the first 6 months after transplantation.
Trial: 30575346
Drug: Standard immunosuppression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard immunosuppression therapy (tacrolimus, mycophenolate, prednisone) without photopheresis.
Trial: 23926253
Drug: Cabergoline (selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabergoline (selective D2/D3 agonist)
Trial: 20622414
Drug: Pharmacotherapy (Arm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy (Arm 4)
Trial: 20622414
Drug: Health education
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health education and behavioral therapy (not specified if part of the intervention arms)
Trial: 14763194
Drug: Quinacrine pellets
RxNorm normalized name: quinacrine
DrugBank: Quinacrine (DB01103)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinacrine pellets (252 mg total, 36 mg per pellet, three applications)
Trial: 10944481
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A (VA) intervention - 16,700 IU weekly
Trial: 2940938
Drug: Midazolam (0.82
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.82 mg/kg) plus Ketamine (2.0 mg/kg i.m.)
Trial: 2940938
Drug: Diazepam (not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (not specified dosage) plus Ketamine (2.0 mg/kg i.m.)
Trial: 2940938
Drug: Ketamine (2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (2.4 mg/kg i.m. alone)
Trial: 31558380
Drug: Multicomponent intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multicomponent intervention including educational in-service, evidence-based tools for assessing neuropsychiatric symptoms, and monthly interprofessional team meetings
Trial: 30589048
Drug: Chronomodulated chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronomodulated chemotherapy (CC group) with cisplatin at 80 mg/m2 from 10:00 to 22:00 and 5-fluorouracil (5-FU) at 1000 mg/m2 plus citrovorum factor at 200 mg/m2 from 22:00 to 10:00 for 3 days.
Trial: 30589048
Drug: Routine chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine chemotherapy (RC group) with cisplatin infusion within 1 h and 5-FU infusion for about 24 h, same dosage as CC group.
Trial: 30589048
Drug: Chronomodulated chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronomodulated chemotherapy (CC group)
Trial: 30589048
Drug: Routine chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine chemotherapy (RC group)
Trial: 25161021
Drug: Meropenem 1000mg,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem 1000mg, 30-minute infusion
Trial: 25161021
Drug: Meropenem 500mg,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem 500mg, 3-hour infusion
Trial: 15904635
Drug: Rosuvastatin at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin at 10 mg
Trial: 15904635
Drug: Atorvastatin, pravastatin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin, pravastatin, and simvastatin
Trial: 9728642
Drug: Paroxetine (initially
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (initially 20 mg, flexible dosing up to 50 mg/d)
Trial: 8158888
Drug: Protein-restricted diet
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein-restricted diet (0.4 g per kg)
Trial: 759617
Drug: Alphaprodine 0.135
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alphaprodine 0.135 mg/kg
Trial: 759617
Drug: Alphaprodine 0.270
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alphaprodine 0.270 mg/kg
Trial: 759617
Drug: Meperidine 0.564
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 0.564 mg/kg
Trial: 759617
Drug: Meperidine 1.127
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine 1.127 mg/kg
Trial: 24511708
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (1000 mg day(‐1))
Trial: 21483189
Drug: Chest tube
RxNorm normalized name: Kids-Eeze Chest Relief
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chest tube removal at 200 ml/day (trial group)
Trial: 21483189
Drug: Chest tube
RxNorm normalized name: Kids-Eeze Chest Relief
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chest tube removal at 150 ml/day (control group)
Trial: 9596205
Drug: DZP rectal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DZP rectal gel (15 mg)
Trial: 9596205
Drug: Intravenous DZP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous DZP (7.5 mg)
Trial: 7850397
Drug: True electroconvulsive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: True electroconvulsive therapy (ECT)
Trial: 11571237
Drug: ALT‐711 (210
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALT‐711 (210 mg)
Trial: 21410446
Drug: Number of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Number of drugs added to a participant's medication regimen during the 1‐year study period
Trial: 19628217
Drug: T‐cell receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T‐cell receptor excision circles (TRECs) quantification using neonatal Guthrie cards
Trial: 8454796
Drug: Solidified benzyl
RxNorm normalized name: Benzyl Alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Solidified benzyl benzoate and tenside agents (A)
Trial: 3961072
Drug: Alcohol group,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol group, drinking .08 ml of pure alcohol per kg body weight
Trial: 18574364
Drug: Gabapentin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (300 mg b.i.d. from day 1 to 3, 300 mg q.i.d. from day 4 to 6, and 600 mg t.i.d. from day 7 to 10)
Trial: 15906167
Drug: Talinolol in
RxNorm normalized name: talinolol Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Talinolol in fast-disintegrating capsules with food
Trial: 15906167
Drug: Talinolol in
RxNorm normalized name: talinolol Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Talinolol in enteric-coated capsules
Trial: 15906167
Drug: Talinolol in
RxNorm normalized name: talinolol Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Talinolol in rectal capsules
Trial: 12641984
Drug: Glutamine dipeptide
RxNorm normalized name: Alanyl-glutamine dipeptide
DrugBank: Alanyl glutamine (DB11876)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glutamine dipeptide (0.5 g/kg/day, orally in bolus)
Trial: 10426876
Drug: IIb-IIIa platelet
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IIb-IIIa platelet receptor antagonists
Trial: 30819157
Drug: Removing drug
RxNorm normalized name: Super Spot Remover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Removing drug mark-ups
Trial: 30819157
Drug: Removing drug
RxNorm normalized name: Super Spot Remover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Removing drug markups
Trial: 18984393
Drug: Mini-implants (miniplates,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mini-implants (miniplates, miniscrews, or microscrews)
Trial: 18984393
Drug: Traditional anchorage
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional anchorage preparation with a transpalatal arch and headgear
Trial: 18984393
Drug: Mini-implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mini-implants
Trial: 10235220
Drug: 10 million
RxNorm normalized name: Interferon Alfa-2b 10 MILLION IU/1 ML Injection Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 million units alpha-N1 IFN i.m. t.w. for 24 wk (total dose: 720 million units)
Trial: 1859007
Drug: ORG9426 0.12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ORG9426 0.12 mg/kg
Trial: 1859007
Drug: ORG9426 0.16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ORG9426 0.16 mg/kg
Trial: 1859007
Drug: ORG9426 0.20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ORG9426 0.20 mg/kg
Trial: 1859007
Drug: ORG9426 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ORG9426 0.6 mg/kg (group 1)
Trial: 1859007
Drug: ORG9426 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ORG9426 0.6 mg/kg (group 2)
Trial: 6353523
Drug: L-tryptophan (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-tryptophan (1 g)
Trial: 22677260
Drug: Docetaxel (D)
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel (D) 75 mg/m² every 3 weeks with prednisone
Trial: 22677260
Drug: Docetaxel (D)
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel (D) 75 mg/m² every 3 weeks with prednisone and Risedronate (DR) 30 mg oral once daily
Trial: 12296840
Drug: Various cancer
RxNorm normalized name: various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various cancer treatments; specific interventions not detailed; focus on quality of life measures using standardized schedules.
Trial: 9806651
Drug: Surgery alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery alone or in combination with radiation for regional disease
Trial: 9806651
Drug: Chemotherapy for
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy for distant disease
Trial: 1659438
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose naloxone
Trial: 24078028
Drug: Continuous intradermal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intradermal sutures
Trial: 23034962
Drug: Dietary phylloquinone
RxNorm normalized name: Phylloquinone
DrugBank: Phylloquinone (DB01022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary phylloquinone intake (100 μg phylloquinone/d)
Trial: 15465973
Drug: Low-dose ketamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ketamine (0.1 mg/kg)
Trial: 15465973
Drug: High-dose ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ketamine (0.5 mg/kg)
Trial: 8076620
Drug: Glucose ingestion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose ingestion (50 g at time 0 min and 25 g at time 60 and 120 min)
Trial: 25881462
Drug: Yiqi Huoxue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yiqi Huoxue Decoction (YHD), one dose daily for 14 days
Trial: 25881462
Drug: Routine symptomatic
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine symptomatic treatment (Group A)
Trial: 20564681
Drug: Analgesic
RxNorm normalized name: Analgesic
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic
Trial: 15139072
Drug: Tibetan yoga
RxNorm normalized name: ibritumomab tiuxetan
DrugBank: Ibritumomab tiuxetan (DB00078)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tibetan yoga (TY) intervention, 7 weekly yoga sessions
Trial: 11339516
Drug: diclofenac 150
RxNorm normalized name: diclofenac sodium 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diclofenac 150 mg
Trial: 8432915
Drug: rIFN-gamma (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rIFN-gamma (50 micrograms/m2 daily subcutaneous injection for 12 weeks)
Trial: 31711704
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg CoQ10/kg diet
Trial: 31711704
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg CoQ10/kg diet
Trial: 31711704
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg CoQ10/kg diet (Control)
Trial: 27015659
Drug: Exercise intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exercise intervention (4-month moderate- to hard-intensity exercise training programme, 29 one-hour classes, twice weekly)
Trial: 24072136
Drug: Innovator drug
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Innovator drug (Omnipaque)
Trial: 24072136
Drug: Generic drug
RxNorm normalized name: CELECOXIB 200 mg ORAL CAPSULE [Generic drug]
DrugBank: Memantine (DB01043)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Generic drug (Iopaque)
Trial: 21902684
Drug: Lenalidomide plus
RxNorm normalized name: Lenalidomide
DrugBank: Lenalidomide (DB00480)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lenalidomide plus dexamethasone (low or high doses)
Trial: 18239240
Drug: Herbal supplement
RxNorm normalized name: LYDIA PINKHAM Herbal Supplement Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal supplement
Trial: 10942063
Drug: Bendamustine 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendamustine 80 mg/m2
Trial: 10942063
Drug: Bendamustine 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendamustine 60 mg/m2
Trial: 10942063
Drug: Bendamustine 70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendamustine 70 mg/m2
Trial: 10942063
Drug: Bendamustine (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendamustine (all doses)
Trial: 8782844
Drug: Pravastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (40 mg twice a day)
Trial: 1619943
Drug: MMC 12
RxNorm normalized name: MMC
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MMC 12 mg/m2 intravenously on day 1 and OK‐432 5 KE intradermally on days 6, 8, and 11
Trial: 1619943
Drug: MMC 12
RxNorm normalized name: MMC
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MMC 12 mg/m2 alone followed by long‐term tegafur
Trial: 30470229
Drug: Atorvastatin 20
RxNorm normalized name: atorvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 20 mg/d combined with ezetimibe 10 mg/d (A20E10 group, n=48)
Trial: 30470229
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg/d (A40 group, n=50)
Trial: 27798770
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg SOFE (50 mg hydroxytyrosol)
Trial: 27798770
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg SOFE (100 mg hydroxytyrosol)
Trial: 18250251
Drug: Naltrexone hydrochloride
RxNorm normalized name: Naltrexone Hydrochloride
DrugBank: Naltrexone (DB00704)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naltrexone hydrochloride (100 mg) with medical management (MM) alone
Trial: 18250251
Drug: Naltrexone hydrochloride
RxNorm normalized name: Naltrexone Hydrochloride
DrugBank: Naltrexone (DB00704)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naltrexone hydrochloride (100 mg) with combined behavioral intervention (CBI)
Trial: 10216805
Drug: Eprosartan (200‐300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eprosartan (200‐300 mg b.i.d.)
Trial: 10216805
Drug: Enalapril (5‐20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (5‐20 mg o.d.)
Trial: 8801328
Drug: Dilapress 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilapress 240 (formulation A) single dose (240 mg)
Trial: 8801328
Drug: Dilapress 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilapress 240 (formulation A) multiple dose (240 mg qd for 6 days)
Trial: 8801328
Drug: Cardizem CD
RxNorm normalized name: Cardizem CD
DrugBank: Diltiazem (DB00343)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cardizem CD (formulation B)
Trial: 8801328
Drug: Dilapress 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilapress 240 (formulation A) single dose (240 mg) without subject 8
Trial: 8801328
Drug: Dilapress 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilapress 240 (formulation A) and Cardizem CD (formulation B)
Trial: 2196146
Drug: Dextroamphetamine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextroamphetamine (up to 1.5 mg/kg/day)
Trial: 2196146
Drug: Methylphenidate (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (up to 3.0 mg/kg/day)
Trial: 31103
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg oral dose before anaesthesia
Trial: 31310855
Drug: Apixaban plus
RxNorm normalized name: Apixaban
DrugBank: Apixaban (DB06605)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Apixaban plus aspirin
Trial: 31310855
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (apixaban, thienopyridine, and aspirin)
Trial: 31310855
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy (apixaban plus aspirin)
Trial: 24107881
Drug: Psychosocial group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychosocial group therapy (PST) for 3 months
Trial: 24107881
Drug: Psychosocial group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychosocial group therapy (PST)
Trial: 20209977
Drug: Acupuncture-assisted anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture-assisted anesthesia (AAA) group: electroacupuncture (EA, 2 Hz/100 Hz, 9 mA) applied to Changqiang (GV 1) and Yaoshu (GV 2) for 20 min, and 1% lidocaine (5 mL) injected into GV 1.
Trial: 20209977
Drug: Control group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group: 20 mL and 10 mL of 1% lidocaine injected into GV 2 and GV 1, respectively.
Trial: 8001520
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of slow release ascorbic acid, 100 micrograms of organic selenium, 200 mg of D‐alpha‐tocopheryl acetate and 30 mg of beta‐carotene daily for 3 months
Trial: 3042874
Drug: Dexamethasone (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (initial dose, 3 mg/kg; total, 11.4 mg/kg per 48 h)
Trial: 30915444
Drug: Higher intake
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher intake of lutein plus zeaxanthin (L + Z)
Trial: 28370447
Drug: Dextromethorphan/quinidine (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextromethorphan/quinidine (45 mg/10 mg twice daily)
Trial: 21740445
Drug: Gamma irradiation
RxNorm normalized name: Gamma Cyclodextrin
DrugBank: Gamma cyclodextrin (DB19173)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gamma irradiation (60 Gy in daily increments of 2 Gy)
Trial: 16607109
Drug: Ultralow-dose transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultralow-dose transdermal estradiol at 0.014 mg/d
Trial: 14682655
Drug: Oxalate desensitizing
RxNorm normalized name: oxalate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxalate desensitizing agent
Trial: 10953672
Drug: Cereal-based foods
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cereal-based foods (chapatti, idli, poori) containing 50 g carbohydrate
Trial: 10953672
Drug: Reference glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference glucose load (50 g)